193 related articles for article (PubMed ID: 12509841)
1. Do calcium channel autoantibodies cause cerebellar ataxia with Lambert-Eaton syndrome?
Fletcher CF; Lennon VA
Ann Neurol; 2003 Jan; 53(1):5-7. PubMed ID: 12509841
[No Abstract] [Full Text] [Related]
2. A case report of the efficient reduction of calcium channel antibodies by tryptophan ligand immunoadsorption in a patient with Lambert-Eaton syndrome.
Sauter M; Bender A; Heller F; Sitter T
Ther Apher Dial; 2010 Jun; 14(3):364-7. PubMed ID: 20609193
[TBL] [Abstract][Full Text] [Related]
3. [Paraneoplastic neurologic syndromes. 2. Lambert-Eaton myasthenic syndrome. 2) Anti-calcium channel antibody and clinical features].
Nakao Y; Motomura M; Suenaga A; Nakamura T; Yoshimura T; Tsujihata M; Ito M; Kono S; Eguchi K
Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):685-90. PubMed ID: 9627478
[No Abstract] [Full Text] [Related]
4. [Lambert-Eaton syndrome without calcium channel autoantibodies].
Delpont E; Martin-Moutot N; Brunetto JL; Desnuelle C
Rev Neurol (Paris); 1994; 150(3):244-7. PubMed ID: 7863174
[TBL] [Abstract][Full Text] [Related]
5. Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome.
Fukuda T; Motomura M; Nakao Y; Shiraishi H; Yoshimura T; Iwanaga K; Tsujihata M; Eguchi K
Ann Neurol; 2003 Jan; 53(1):21-8. PubMed ID: 12509844
[TBL] [Abstract][Full Text] [Related]
6. Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
Lorenzoni PJ; Scola RH; Lang B; Kay CS; Teive HA; Kowacs PA; Werneck LC
J Neurol Sci; 2008 Jul; 270(1-2):194-6. PubMed ID: 18374949
[TBL] [Abstract][Full Text] [Related]
7. Specificity of autoantibodies react with omega-conotoxin MVIIC-sensitive calcium channel in Lambert-Eaton myasthenic syndrome.
Suenaga A; Shirabe S; Nakamura T; Motomura M; Tsujihata M; Matsuo H; Kataoka Y; Niwa M; Itoh M; Nagataki S
Muscle Nerve; 1996 Sep; 19(9):1166-8. PubMed ID: 8761275
[No Abstract] [Full Text] [Related]
8. Absence of anti-P/Q calcium channel antibody in the sera of patients with anti-Yo antibody-positive paraneoplastic cerebellar degeneration.
Tanaka K; Motomura M; Nakao Y; Tanaka M; Tsuji S
Neurology; 1997 Sep; 49(3):895-6. PubMed ID: 9305368
[No Abstract] [Full Text] [Related]
9. Lambert-Eaton myasthenic syndrome. Antigenicity of recombinant human P/Q-type calcium channel alpha 1 subunit putative ion pore region (domain IV, S5-S6).
Black JL; Griesmann GE; Erickson J; Kryzer TJ; Lamke GT; Lennon VA
Ann N Y Acad Sci; 1998 May; 841():691-5. PubMed ID: 9668316
[No Abstract] [Full Text] [Related]
10. Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum.
Arsac C; Raymond C; Martin-Moutot N; Dargent B; Couraud F; Pouget J; Seagar M
Ann Neurol; 1996 Nov; 40(5):695-700. PubMed ID: 8957009
[TBL] [Abstract][Full Text] [Related]
11. Calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome.
Leys K; Lang B; Vincent A; Newsom-Davis J
Lancet; 1989 Nov; 2(8671):1107. PubMed ID: 2572837
[No Abstract] [Full Text] [Related]
12. [Paraneoplastic neurologic syndromes. 2. Lambert-Eaton myasthenic syndrome. 1) The molecular structure of calcium channel and immunology].
Komai K; Iwasa K; Takamori M
Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):678-84. PubMed ID: 9627477
[No Abstract] [Full Text] [Related]
13. Sera from patients with Lambert-Eaton myasthenic syndrome recognize the beta-subunit of Ca2+ channel complexes.
Rosenfeld MR; Wong E; Dalmau J; Manley G; Egan D; Posner JB; Sher E; Furneaux HM
Ann N Y Acad Sci; 1993 Jun; 681():408-11. PubMed ID: 8395157
[No Abstract] [Full Text] [Related]
14. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
15. [Lambert-Eaton myasthenic syndrome and myasthenia gravis].
Takamori M; Iwasa K; Komai K; Yasukawa Y
No To Shinkei; 1997 Dec; 49(12):1089-100. PubMed ID: 9453039
[No Abstract] [Full Text] [Related]
16. Autoantibody specificities in Lambert-Eaton myasthenic syndrome.
Lang B; Johnston I; Leys K; Elrington G; Marqueze B; Leveque C; Martin-Moutot N; Seagar M; Hoshino T; Takahashi M
Ann N Y Acad Sci; 1993 Jun; 681():382-93. PubMed ID: 8395152
[No Abstract] [Full Text] [Related]
17. Subacute cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with antibodies to voltage-gated calcium channels: differential effect of immunosuppressive therapy on central and peripheral defects.
Goldstein JM; Waxman SG; Vollmer TL; Lang B; Johnston I; Newsom-Davis J
J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1138-9. PubMed ID: 8089692
[No Abstract] [Full Text] [Related]
18. Phoneutria nigriventer omega-Phonetoxin IIA: a new tool for anti-calcium channel autoantibody assays in Lambert-Eaton myasthenic syndrome.
Martin-Moutot N; Haro Ld; Santos RG; Mori Y; Seagar M
Neurobiol Dis; 2006 Apr; 22(1):57-63. PubMed ID: 16289869
[TBL] [Abstract][Full Text] [Related]
19. [Paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with anti P/Q-type voltage-gated calcium channel antibody in a patient with primary double lung cancer].
Iwanami M; Odaka M; Nakamura T; Hirata K
Brain Nerve; 2009 Sep; 61(9):1083-7. PubMed ID: 19803409
[TBL] [Abstract][Full Text] [Related]
20. Asymptomatic Lambert-Eaton syndrome.
Denys EH; Lennon VA
Muscle Nerve; 2014 May; 49(5):764-7. PubMed ID: 24259319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
